Benefits and risks of sterilization

Obstetrics and Gynecology

Volumn 102, Issue 3, 2003, Pages 647-658

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; INJECTABLE CONTRACEPTIVE AGENT; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER RISK; CLINICAL TRIAL; CONDOM; CONTRACEPTION; ECTOPIC PREGNANCY; ELECTROCOAGULATION; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPIC SURGERY; LAPAROTOMY; MEDICAL PRACTICE; MENSTRUATION DISORDER; ORAL CONTRACEPTION; PATIENT; PATIENT COUNSELING; PATIENT SATISFACTION; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREGNANCY RATE; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RISK ASSESSMENT; SAFETY; SALPINGECTOMY; SEXUAL FUNCTION; SURGICAL APPROACH; SURGICAL EQUIPMENT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TIME; UTERINE TUBE LIGATION; UTERINE TUBE STERILIZATION; VASECTOMY;

EID: 0142157683     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. EngenderHealth. Contraceptive sterilization: global issues and trends. New York: EngenderHealth; 2002. (Level III)
2. MacKay AP, Kieke BA Jr, Koonin LM, Beattie K. Tubal sterilization in the United States, 1994-1996. Fam Plann Perspect 2001;33:161-5. (Level II-3)
3. Magnani RJ, Haws JM, Morgan GT, Gargiullo PM, Pollack AE, Koonin LM. Vasectomy in the United States, 1991 and 1995. Am J Public Health 1999;89:92-4. (Level II-3)
4. Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States:1982-1995. Fam Plann Perspect 1998;30:4-10, 46. (Level II-3)
5. Pollack AE, Soderstrom RM. Female tubal sterilization. In: Corson SL, Derman RJ, Tyrer LB, editors. Fertility control. 2nd ed. London (ON): Goldin Publishers; 1994. p. 293-317. (Level III)
6. Centers for Disease Control. Surgical sterilization surveillance: tubal sterilization 1976-1978. Atlanta (GA): CDC; 1981. (Level II-3)
7. American College of Obstetricians and Gynecologists. Tuba] ligation with cesarean delivery. ACOG Committee Opinion 205. Washington, DC: ACOG; 1998. (Level III)
8. Peterson HB, Pollack AE, Warshaw JS. Tubal sterilization. In: Rock JA, Thompson JD, editors. Te Linde's Operative Gynecology. 8th ed. Philadelphia (PA): Lippincott-Raven; 1997. p. 529-47. (Level III)
9. American College of Obstetricians and Gynecologists. Ethics in obstetrics and gynecology. Washington, DC: ACOG; 2002. (Level III)
10. Akhter HH, Flock ML, Rubin GL. Safety of abortion and tubal sterilizalion performed separately versus concurrently. Am J Obstet Gynecol 1985;152:619-23. (Level II-3)
11. Lipscomb GH, Spellman JR, Ling FW. The effect of same-day pregnancy testing on the incidence of luteal phase pregnancy. Obstet Gynecol 1993;82:411-3. (Level II-3)
12. Kasliwal A, Farquharson RG. Pregnancy testing prior to sterilisation. BJOG 2000;107:1407-9. (Level III)
13. Lichter ED, Laff SP, Friedman EA. Value of routine dilatalion and curettage at the time of interval sterilization. Obstet Gynecol 1986;67:763-5. (Level III)
14. Valle RF, Carignan CS, Wright TC. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril 2001;76:974-80. (Level III)
15. Hartfield VJ. Female sterilization by the vaginal route: a positive reassessment and comparison of 4 tubal occlusion methods. Aust N Z J Obstet Gynaecol 1993;33:408-12. (Level II-1)
16. Peterson HB, Xia Z, Wilcox LS, Tylor LR, Trussell J. Pregnancy after tubal sterilization with bipolar electrocoagulation. U.S. Collaborative Review of Sterilization Working Group. Obstet Gynecol 1999;94:163-7. (Level II-2)
17. Soderstrom RM, Levy BS, Engel T. Reducing bipolar sterilization failures. Obstet Gynecol 1989;74:60-3. (Level III)
18. Sokal D, Gates D, Amatya R, Dominik R. Two randomized controlled trials comparing the tubal ring and filschie clip for tubal sterilization. Fertil Steril 2000;74:525-33. (Level I)
19. Dominik R, Gates D, Sokal D, Cordero M, Lasso de la Vega J, Remes Ruiz A, et al. Two randomized controlled trials comparing the Hulka and Filshie Clips for tubal sterilization. Contraception 2000;62:169-75. (Level I)
20. Hieu DT, Tan TT, Tan ND, Nguyet PT, Than P, Vinh DQ. 31,781 cases of non-surgical female sterilization with quinacrine pellets in Vietnam. Lancet 1993;342:213-7. (Level II-1)
21. Mumford SD, Kessel E. Sterilization needs in the 1990s: the case for quinacrine nonsurgical female sterilization. Am J Obstet Gynecol 1992;167:1203-7. (Level III)
22. Mosher WD, Pratt WF. Use of contraception and family planning services in the United States, 1988. Am J Public Health 1990;80:1132-3. (Level II-3)
23. Marquette CM, Koonin LM, Antarsh L, Gargiullo PM, Smith JC. Vasectomy in the United States, 1991. Am J Public Health 1995;85:644-9. (Level II-3)
24. Peterson HB, Huber DH, Belker AM. Vasectomy: an appraisal for the obstetrician-gynecologist. Obstet Gynecol 1990;76:568-72. (Level III)
25. Alderman PM. Complications in a series of 1224 vasectomies. J Fam Pract 1991;33:579-84. (Level III)
26. Sokal D, McMullen S, Gates D, Dominik R. A comparative study of the no scalpel and standard incision approaches to vasectomy in 5 countries. The Male Sterilization Investigator Team. J Urol 1999;162:1621-5. (Level I)
27. Arellano Lara S, Gonzales Barrera JL, Hernandez Ono A, Moreno Alcazar O, Espinosa Perez J. No-scalpel vasectomy: review of the first 1,000 cases in a family medicine unit. Arch Med Res 1997;28:517-22. (Level II-3)
28. Giovannucci E, Tosteson TD, Speizer FE, Vessey MP, Colditz GA. A long-term study of mortality in men who have undergone vasectomy. N Engl J Med 1992;326:1392-8. (Level II-2)
29. Nienhuis H, Goldacre M, Seagroatt V, Gill L, Vessey M. Incidence of disease after vasectomy: a record linkage retrospective cohort study. BMJ 1992;304:743-6. (Level III)
30. Schuman LM, Coulson AH, Mandel JS, Massey FJ Jr, O'Fallon WM. Health Status of American Men - a study of post-vasectomy sequelae. J Clin Epidemiol 1993;46:697-958. (Level II-2)
31. Moller H, Knudsen LB, Lynge E. Risk of testicular cancer after vasectomy: cohort study of over 73,000 men. BMJ 1994;309:295-9. (Level II-2)
32. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group. BMJ 1994;308:1393-9. (Level II-2)
33. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993:269:873-7. (Level II-2)
34. Cox B, Sneyd MJ, Paul C, Delahunt B, Skegg DC. Vasectomy and risk of prostate cancer. JAMA 2002;287:3110-5. (Level II-2)
35. Escobedo LG, Peterson HB, Grubb GS, Franks AL. Case-fatality rates for tuba] sterilization in U.S. hospitals, 1979 to 1980. Am J Obstet Gynecol 1989;160:147-50. (Level III)
36. Hulka JF, Phillips JM, Peterson HB, Surrey MW. Laparoscopic sterilization: American Association of Gynecologic Laparoscopists' 1993 membership survey. J Am Assoc Gynecol Laparosc 1995;2:137-8. (Level III)
37. Peterson HB, Ory HW, Greenspan JR, Tyler CW Jr. Deaths associated with laparoscopic sterilization by unipolar electrocoagulating devices, 1978 and 1979. Am J Obstet Gynecol 1981;139:141-3. (Level II-3)
38. Peterson HB, Hulka JF, Phillips JM, Surrey MW. Laparoscopic sterilization. American Association of Gynecologic Laparoscopists 1991 membership survey. J Reprod Med 1993;38:574-6. (Level III)
39. Peterson HB, DeStefano F, Rubin GL, Greenspan JR, Lee NC, Ory HW. Deaths attributable to tubal sterilization in the United States, 1977-81. Am J Obstet Gynecol 1983;146:131-6. (Level II-3)
40. Jamieson DJ, Hillis SD, Duerr A, Marchbanks PA, Costello C, Peterson HB. Complications of interval ]aparascopic tuba] sterilization: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 2000;96:997-1002. (Level II-2)
41. Chi IC, Petta CA, McPheeters M. A review of safety, efficacy, pros and cons, and issues of puerperal tubal sterilization - an update. Adv Contracept 1995;11:187-206. (Level III)
42. Trussell J, Vaugban B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:64-72, 93, (Level II-3)
43. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996;174:1161-8;discussion 1168-70. (Level II-2)
44. Fortney JA, Feldblum PJ, Raymond EG. Intrauterine devices. The optimal long-term contraceptive method? J Reprod Med 1999;44:269-74. (Level III)
45. Andersson K, Odlind V, Rybo G. Levonorgesterel-releasing and copper releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72. (Level I)
46. Sivin I, el Mahgoub S, McCarthy T, Mishell DR Jr, Shoupe D, Alvarez F, et al. Long-term contraception with the levonorgesterel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five year randomized study. Contraception 1990;42:361-78. (Level I)
47. Luukkainen T, Allonen H, Haukkamaa M, Lahteenmaki P, Nilsson CG, Toivonen J. Five years' experience with levonorgesterel-releasing IUDs. Contraception 1986;33:139-48. (Level I)
48. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 1997;336:762-7. (Level II-2)
49. Kahn HS, Tyler CW Jr. Mortality associated with use of IUDs. JAMA 1975;234:57-9. (Level III)
50. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception 1997;56:341-52. (Level I)
51. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785-8. (Level III)
52. Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1-6. (Level II-2)
53. The TCu380A, TCu220C, multiload 250 and Nova T IUD at 3, 5 and 7 years of use - resu]ts from three randomized multicentre trials. World Hea]th Organization. Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Safety and Efficacy of Fertility Regulating Methods. Contraception 1990;42:141-58. (Level I)
54. Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995;52:269-76. (Level III)
55. Chaim W, Mazor M. Pregnancy wilh an intrauterine device in situ and preterm delivery. Arch Gynecol Obstet 1992;252:21-4. (Level II-2)
56. Foreman H, Stadel BV, Schlesselman S. Intrauterine device usage and fetal loss. Obstet Gynecol 1981;58:669-77. (Level II-2)
57. Tatum HJ, Schmidt FH, Jain AK. Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device. Am J Obstet Gynecol 1976;126:869-79 (Level II-2)
58. Massey FJ Jr, Bernstein GS, O'Fallon WM, Schuman LM, Coulson AH, Crozier R, et al. Vasectomy and health. Results from a large cohort study. JAMA 1984;252:1023-9. (Level II-2)
59. Franks AL, Beral V, Cates W Jr, Hogue CJ. Contraception and ectopic pregnancy risk. Am J Obstet Gynecol 1990;163:1120-3. (Level III)
60. Alder E, Cook A, Gray J, Tyrer G, Warner P, Bancroft J, et al. The effects of sterilisation: a comparison of sterilized women with wives of vasectomized men. Contraception 1981;23:45-54. (Level III)
61. Gentile GP. Kaufman SC. Helbig DW. Is there any evidence for a post-tubal sterilization syndrome? Fertil Steril 1998;69:179-86. (Level III)
62. Poma PA. Tubal sterilization and later hospitalizations. J Reprod Med 1980;25:272-8. (Level II-2)
63. Bhiwandiwala PP. Mumford SD. Feldblum PJ. Menstrual pattern changes following laparoscopic sterilization wilh different occlusion techniques: a review of 10,004 cases. Am J Obstet Gynecol 1983;145:684-94. (Level 11-3)
64. DeStefano F. Perlman JA, Peterson HB. Diamond EL. Long-term risk of menstrual disturbances after tubal sterilization. Am J Obstet Gynecol 1985;152:835-41. (Level II-2)
65. Foulkes J, Chamberlain G. Effects of sterilization on menstruation. South Med J 1985;78:544-7. (Level II-2)
66. Rivera R, Gaitan JR, Ruíz R, Hurley DP, Arenas M, Flores C, et al. Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion. Contraception 1989;40:157-69. (Level I)
67. Rulin MC, Davidson AR, Philliber SG, Graves WL. Long-term effect of tubal sterilization on menstrual indices and pelvic pain. Obstet Gynecol 1993;82:118-21. (Level II-2)
68. Sahwi S, Toppozada M, Kamel M, Anwar MY, Ismail AA. Changes in menstrual blood loss after four methods of female tubal sterilization. Contraception 1989;40: 387-98. (Level I)
69. Tharanov I, Hertz JB, Kjer JJ, Andresen A, Micic S, Nielsen J, et al. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filschie-clips. Fertil Steril 1992;57:751-5. (Level II-3)
70. Peterson HB, Jeng G, Folger SG, Hillis SA, Marchbanks PA, Wilcox LS. The risk of menstrual abnormalities after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 2000;343:1681-7. (Level II-2)
71. Hillis SD, Marchbanks PA, Tylor LR, Peterson HB. Higher hysterectomy risk for sterilized than nonsterilized women: findings from the U.S. Collaborative Review of Sterilization. The U.S. Collaborative Review of Sterilization Working Group. Obstet Gynecol 1998;91: 241-6. (Level II-2)
72. Cohen MM. Long-term risk of hysterectomy after tubal sterilization. Am J Epidemiol 1987;125:410-9. (Level II-2)
73. Goldhaber MK, Armstrong MA, Golditch IM, Sheehe PR, Petitti DB, Friedman GD. Long-term risk of hysterectomy among 80,007 sterilized and comparison women at Kaiser Permanente, 1971-1987. Am J Epidemiol 1993;138:508-21. (Level II-2)
74. Kendrick IS, Rubin GL, Lee NC, Schulz KF, Peterson HB, Nolan TF. Hysterectomy performed within 1 year after tubal sterilization. Fertil Steril 1985;44:606-10. (Level II-2)
75. Stergachis A, Shy KK, Grothaus LC, Wagner EH, Hecht JA, Anderson G, et al. Tubal sterilization and the long-term risk of hysterectomy. JAMA 1990;264:2893-8. (Level II-2)
76. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856-60. (Level III)
77. Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-84. Am J Public Health 1988;78:852-3. (Level II-3)
78. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-55. (Level III)
79. Green A, Purdie D. Bain C. Siskind V, Russell P, Quinn M, et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer 1997;71:948-51. (Level II-2)
80. Hankinson SE, Hunter DJ, Colditz GA, Willett WC, Stampfer MJ, Rosner B, et al. Tubal ligation, hysterectomy and risk of ovarian cancer. A prospective study. JAMA 1993;270:2813-18. (Level II-2)
81. Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991;134: 362-9. (Level II-2)
82. Miracle-McMahill HL, Calle EE, Kosinski AS, Rodriguez C, Wingo PA, Thun MJ, et al. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol 1997;145:349-57. (Level II-2)
83. Cooper JE, Bledin KD, Brice B, Mackenzie S. Effects of female sterilization: one year follow-up in a prospective controlled study of psychological and psychiatric outoomes. J Psychosom Res 1985;29:13-22. (Level II-2)
84. Costello C, Hillis SD, Marchbanks PA, Jamieson DJ, Peterson HB. The effect of interval tubal sterilization on sexual interest and pleasure. Obstet Gynecol 2002;100: 511-7. (Level lI-2)
85. Surgical sterilization among women and use of condoms - Baltimore, 1989-1990. MMWR Morb Mortal Wkly Rep 1992;41:568-9, 575. (Level II-2)
86. HIV-risk behaviors of sterilized and nonsterilized women in drug-treaunent programs - Philadelphia, 1989 1991. MMWR Morb Mortal Wkly Rep 1992,41:149-52. (Level II-2)
87. Green MM, Vicario SJ, Sanfilippo JS, Lochhead SA. Acute pelvic inflammatory disease after surgical sterilization. Ann Emerg Med 1991;20:344-7. (Level III)
88. Reedy MB, Galan HL, Paltorson KM. Acute pelvic inflammatory disease after tubal sterilization. A report of three cases. J Reprod Meal 1994;39:752-4. (Level III)
89. Weeks AG, Entman SS. Gonococcal peritonitis after tubal ligation. A case report. J Reprod Med 1991:36:683-4. (Level III)
90. Hillis SD, Marchbanks PA, Tylor LR, Peterson HB. Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 1999;93:889-95. (Level II-2)
91. Jamieson DJ, Kaufman SC, Costello C, Hillis SD, Marchbanks PA, Peterson HB. A comparison of women's regret after vasectomy versus tubal sterilization. Obstet Gynecol 2002;1073-9. (Level 11-2)
92. Schmidt JE, Hillis SD, Marchbanks PA, Jeng G, Peterson HB. Requesting intbrmation about and obtaining reversal after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Fertil Steril 2000;74:892-8. (Level II-2)
93. Barlfai G, Kaali SG. Late sequelae following laparoscopic female sterilization. Int J Fertil 1989;34:67-71). (Level II-3)
94. Boring CC, Rochat RW, Becerra J. Sterilization regret among Puerto Rican women. Fertil Steril 1988;49:973-81. (Level II-2)
95. Kjier JJ. Regret of laparoscopic sterilization. Eur J Obstet Gynecol Reprod Biol 1990;35:205-10. (Level II-2)
96. Rosenfeld JA, Zahorik PM, Saint W, Murphy G. Women's satisfaction with birth control. J Fam Pract 1993;36:169-73. (Level II-2)
97. Tang CS, Chung TK. Psychosexual adjustment following sterilization: a prospective study on Chinese women. J Psychosom Res 1997;42:187-96. (Level II-2)
98. Chick PH, Frances M, Paterson PJ. A comprehensive review of female sterilisation - tubal occlusion methods. Clin Reprod Fertil 1985;3:81-97. (Level III)
99. Miller WB, Shain RN, Pasta DJ. The predictors of post-sterilization regret in married women. J Appl Soc Psychol 1991;21:1083-11O. (Level II-2)
100. Neuhaus W. Bolte A. Prognostic factors for preoperative consultation of women desiring sterilization: findings of a retrospective analysis. J Psychosom Obstet Gynecol 1995;16:45-50. (Level III)
101. Wilcox LS, Chu SY, Eaker ED, Zeger SL, Peterson HB. Risk factors for regret after tubal sterilization: 5 years of follow up in a prospective study. Fertil Steril 1991;55:927-33. (Level lI-2)
102. Cheng MC, Cheong J, Ratnam SS, Belsey MA, Edstrom KE, Pinol A, et al. Psychosocial sequelae of abortion and sterilization: a controlled study of 200 women randomly allocated to either a concurrent or interval abortion and sterilization. Asia Oceania J Obstet Gynecol 1986;12: 193-200. (Level I)
103. Wilcox LS, Chu SY, Peterson HB. Characteristics of women who or considerd or obtained tubal reanastomosis: results from a prospective study of tubal sterilization. Obstet Gynecol 1990;75:661-5. (Level II-2)
104. Hardy E, Bahamondes L, Osis MJ, Costa RG, Faundes A. Risk factors for tubal sterilization regret, detectable before surgery. Contraception 1996;54:159-62. (Level II-2)